ACEI

(redirected from angiotensin converting enzyme inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to angiotensin converting enzyme inhibitor: Angiotensin receptor blocker
AcronymDefinition
ACEIAngiotensin Converting Enzyme Inhibitor
ACEIAssociation for Childhood Education International
ACEIAssociation for Cultural Economics International
ACEIAssociation of Consulting Engineers of Ireland
ACEIAlliance for a Competitive European Industry
ACEIAsociacion Caribeña de Evaluacion e Investigacion
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Combining an angiotensin converting enzyme inhibitor (ACE-I) with a thiazide, [beta]-blocker, or calcium channel blocker produces side effects similar to monotherapy, as does combining an angiotensin receptor blocker (ARB) with a thiazide or calcium channel blocker (SOR: A, meta-analyses).
Effects of an angiotensin converting enzyme inhibitor ramipril on cardiovascular events in high-risk patients.
Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.
Hsu, Bates, Kuperman & Curhan (2001), in their study, "Blood pressure and angiotensin converting enzyme inhibitor use in hypertensive patients with chronic renal insufficiency," sought to investigate actual clinical management of hypertension in 3,089 ambulatory patients with CKD by using medical record information from a Massachusetts hospital.
WellStar also follows the percentage of patients receiving angiotensin converting enzyme inhibitor (ACEI) therapy (76 percent) or appropriate alternatives if intolerant to ACEI therapy (13 percent).
For hypertension in nursing home patients, therapeutic substitution of a calcium channel blocker or angiotensin converting enzyme inhibitor (ACEI) may be appropriate to avoid worsening mental dysfunction.
The product is an angiotensin converting enzyme inhibitor approved for the treatment of patients with high blood pressure and it decreases the risk of heart attack in patients with stable coronary artery disease.
Full browser ?